SNY

Sanofi Share Price - SNY

50.85
-1.59 (-3.03%)
Upgrade to Real-Time
Afterhours (Closed)
50.85
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Sanofi SNY NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-1.59 -3.03% 50.85 20:00:00
Close Price Low Price High Price Open Price Previous Close
50.85 50.17 51.06 51.00 52.44
Bid Price Ask Price Spread News
50.11 52.95 2.84 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
6,883 589,749  50.55  29,810,959 934,054 37.62 - 55.00
Last Trade Time Type Quantity Stock Price Currency
18:30:58 16  50.11 USD

Sanofi Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 127.77B 2.51B 2.51B  42.23B  12.28B 1.25 10.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 324.07% - -

more financials information »

News Sanofi

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

SNY Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Lantus, representing just under 10% of total sales. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.